General

1489-1504 of 2456

• 

  RestartResume

  Aganocide Compounds Show Activity Against Ophthalmic Pathogens

  RestartResume

  Aganocide Compounds Show Activity Against Ophthalmic Pathogens

  General

  Aganocide Compounds Show Activity Against Ophthalmic Pathogens

  Conni Bergmann Koury, Executive Editor

  Conni Bergmann Koury, Executive Editor

• 

  RestartResume

  Sidebar: DEALING WITH THE ANGRY OR UNHAPPY PATIENT

  RestartResume

  Sidebar: DEALING WITH THE ANGRY OR UNHAPPY PATIENT

  General

  Sidebar: DEALING WITH THE ANGRY OR UNHAPPY PATIENT

  Michael Gordon, MD

  Michael Gordon, MD

• 

  RestartResume

  Social Graces: Nine Keys to Using Social Media in a Practice Setting

  RestartResume

  Social Graces: Nine Keys to Using Social Media in a Practice Setting

  General

  Social Graces: Nine Keys to Using Social Media in a Practice Setting

  Matt Jensen

  Matt Jensen

• 

  RestartResume

  Ray Tracing: the Future of Refractive Surgery

  RestartResume

  Ray Tracing: the Future of Refractive Surgery

  General

  Ray Tracing: the Future of Refractive Surgery

  Daniel Simon, Dipl Ing; Silvia Schumacher, PHD

  Daniel Simon, Dipl Ing; Silvia Schumacher, PHD

• 

  RestartResume

  Clinical Results of the US T-CAT Study

  RestartResume

  Clinical Results of the US T-CAT Study

  General

  Clinical Results of the US T-CAT Study

  Daniel S. Durrie, MD

  Daniel S. Durrie, MD

• 

  RestartResume

  LASIK: Wavefront-Guided Versus Wavefront - Optimized Technology

  RestartResume

  LASIK: Wavefront-Guided Versus Wavefront - Optimized Technology

  General

  LASIK: Wavefront-Guided Versus Wavefront - Optimized Technology

  Edward E. Manche, MD

  Edward E. Manche, MD

• 

  RestartResume

  The LASIK Market: Yesterday's Technology or Poised for Recovery?

  RestartResume

  The LASIK Market: Yesterday's Technology or Poised for Recovery?

  General

  The LASIK Market: Yesterday's Technology or Poised for Recovery?

  David R. Harmon

  David R. Harmon

• 

  RestartResume

  Is LASIK Dead?

  RestartResume

  Is LASIK Dead?

  General

  Is LASIK Dead?

  Shareef Mahdavi

  Shareef Mahdavi

• 

  RestartResume

  Update on Cross-linking and Patients' Outcomes

  RestartResume

  Update on Cross-linking and Patients' Outcomes

  General

  Update on Cross-linking and Patients' Outcomes

  Shachar Tauber, MD

  Shachar Tauber, MD

• 

  RestartResume

  CORRECTING THE IRREGULAR CORNEA: The Athens Protocol

  RestartResume

  CORRECTING THE IRREGULAR CORNEA: The Athens Protocol

  General

  CORRECTING THE IRREGULAR CORNEA: The Athens Protocol

  A. John Kanellopoulos, MD

  A. John Kanellopoulos, MD

• 

  RestartResume

  MY MOST DIFFICULT CASE: Incorrect IOL Power

  RestartResume

  MY MOST DIFFICULT CASE: Incorrect IOL Power

  General

  MY MOST DIFFICULT CASE: Incorrect IOL Power

  An Anonymous Contributor

  An Anonymous Contributor

• 

  RestartResume

  COMPLEX CASE MANAGEMENT: Visual Potential Decades After Trauma

  RestartResume

  COMPLEX CASE MANAGEMENT: Visual Potential Decades After Trauma

  General

  COMPLEX CASE MANAGEMENT: Visual Potential Decades After Trauma

  Guy Kleinmann, MD; Richard S. Koplin, MD

  Guy Kleinmann, MD; Richard S. Koplin, MD

• 

  RestartResume

  Spectacle Independence After IOL Surgery

  RestartResume

  Spectacle Independence After IOL Surgery

  General

  Spectacle Independence After IOL Surgery

  Mark A. Kontos, MD; Jay S. Pepose MD, PhD, FARVO

  Mark A. Kontos, MD; Jay S. Pepose MD, PhD, FARVO

• 

  RestartResume

  CHIEF MEDICAL EDITOR'S PAGE

  RestartResume

  CHIEF MEDICAL EDITOR'S PAGE

  General

  CHIEF MEDICAL EDITOR'S PAGE

  Stephen Slade, MD

  Stephen Slade, MD

• 

  RestartResume

  5 Questions with Mark Kontos, MD

  RestartResume

  5 Questions with Mark Kontos, MD

  General

  5 Questions with Mark Kontos, MD

• 

  RestartResume

  INNOVATIONS

  RestartResume

  INNOVATIONS

  General

  INNOVATIONS